Based in Finland, ArcDia is a startup founded in 2007. Brouky records 2 investors associated with the company.
ArcDia develops and manufactures rapid antigen-based diagnostic testing systems for acute infections, enabling simultaneous detection of multiple pathogens from a single clinical sample to support decentralized point-of-care testing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.